Skip to content
Open in App
Sichuan Kelun Biotech logo

Sichuan Kelun Biotech

web2

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the...

Symbol · 6990
Company profile

About

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally. The company’s product pipeline includes Sac-TMT, a novel TROP2 ADC positioned as a monotherapy and part of combination therapies for treating various advanced solid tumors; Trastuzumab botidotin, a monotherapy to treat advanced HER2+ solid tumors; SKB315, a novel CLDN18.2 ADC targeting advanced solid tumors; SKB410/MK-3120, a novel Nectin-4 ADC targeting advanced solid tumors; and SKB571/MK-2750, a novel bsADC primarily targeting various solid tumors, such as LC and CRC. The company also develops SKB518, SKB535/MK-6204 and SKB445, which are novel ADC drugs with potential FIC targets; SKB500 and SKB501, which are novel ADC drugs with verified targets but differentiated payload-linker strategies; SKB107, an RDC targeting tumor bone metastases; Tagitanlimab, PD-L1 mAb for its immunotherapy franchise; Cetuximab N01, a recombinant EGFR human-mouse chimeric mAb; A400, a novel selective RET inhibitor; and A296, a novel small molecule STING agonist. It has license and collaboration arrangements with Merck Sharp & Dohme LLC; Harbour BioMed Therapeutics Limited; Windward Bio AG; and Ellipses Pharma Limited. The company has a strategic partnership with Crescent Biopharma, Inc. The company was incorporated in 2016 and is headquartered in Chengdu, the People’s Republic of China. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

YL

Yihong Liao

Non-Executive Chairman

Company leadership profile.

JG

Junyou Ge

President, CEO, COO, GM & Executive Director

Company leadership profile.

GL

Gexin Liu

Non-Executive Director

Company leadership profile.

QZ

Qiang Zheng

Independent Non-Executive Director

Company leadership profile.

YL

Yuedong Li

Independent Non-Executive Director

Company leadership profile.

SL

Sichuan Liu

Non-Executive Director

Company leadership profile.

HF

Hao Feng

Non-Executive Director

Company leadership profile.

XZ

Xuebo Zeng

Non-Executive Director

Company leadership profile.

WT

Wenwei Tu

Independent Non-Executive Director

Company leadership profile.

DL

Degui Lai

Non-Executive Director

Company leadership profile.

JJ

Jinping Jin

Independent Non-Executive Director

Company leadership profile.

HS

Hongmei Song

Supervisor

Company leadership profile.

QY

Qiuyan Yang

Supervisor

Company leadership profile.

YQ

Yan Qing

Supervisor

Company leadership profile.

Expert coverage

1 expert evaluated Sichuan Kelun Biotech.

Orbitrum research

Experts evaluating Sichuan Kelun Biotech

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment